https://www.takeda.com/da-dk/presse/2017/takeda-pharma-as-tilbagekalder-et-parti-pamol-receptpligtig/
Takeda Pharma A/S tilbagekalder et parti Pamol (receptpligtig)
Takeda Pharma A/S tilbagekalder et parti Pamol (receptpligtig)
takeda pharmaetpartipamol
https://www.takeda.com/pl-pl/aktualnosci/2015/dyplom-takeda/
Takeda Pharma otrzymuje dyplom uznania w konkursie Kreator miejsc pracy
Takeda Pharma otrzymuje dyplom uznania w konkursie Kreator miejsc pracy
takeda pharmadyplomwkreatormiejsc
https://www.takeda.com/en-us/newsroom/news-releases/2012/takeda-to-sell-non-colcrys-url-pharma-inc-generic-business-to-sun-pharmaceutical/
Takeda to Sell Non-Colcrys URL Pharma, Inc. Generic Business to Sun Pharmaceutical
Takeda to Sell Non-Colcrys URL Pharma, Inc. Generic Business to Sun Pharmaceutical
to sellurl pharma
https://informaconnect.com/pharmaceutical-compliance-congress-canada/speakers/chrisoula-nikidis/
Chrisoula Nikidis - Takeda | PCC Canada 2026 - Pharma & MedTech Compliance Canada Speaker
takedapcccanada2026pharma
https://www.biospace.com/sumitomo-dainippon-pharma-co-ltd-takeda-terminate-latuda-agreement
Sumitomo Dainippon Pharma Co., Ltd. , Takeda Terminate Latuda Agreement - BioSpace
sumitomo dainippon pharmaco ltdtakedaterminatelatuda
https://www.takeda.com/newsroom/newsreleases/2022/collaboration-and-licensing-agreement-to-develop-celiac-disease-therapy/
Takeda Enters Collaboration and Licensing Agreement with Zedira and Dr. Falk Pharma to Develop...
Takeda Enters Collaboration and Licensing Agreement with Zedira and Dr. Falk Pharma to Develop First-in-Class Celiac Disease Therapy
https://www.takeda.com/newsroom/newsreleases/2015/sumitomo-dainippon-pharma-co-ltd2-and-takeda-pharmaceutical-company--limited-announce-decision-to-terminate-their-agreement-for-the-joint/
Sumitomo Dainippon Pharma Co. Ltd. and Takeda Pharmaceutical Company Limited Announce Decision to...
Sumitomo Dainippon Pharma Co. Ltd. and Takeda Pharmaceutical Company Limited Announce Decision to Terminate their Agreement for the Joint Development and...
sumitomo dainippon pharmatakeda pharmaceutical company
https://www.takeda.com/newsroom/newsreleases/2021/takeda-completes-sale-of-four-diabetes-products-in-japan-to-teijin-pharma-limited/
Takeda Completes Sale of Four Diabetes Products in Japan to Teijin Pharma Limited
Takeda Completes Sale of Four Diabetes Products in Japan to Teijin Pharma Limited
https://www.biospace.com/takeda-pharmaceutical-co-ltd-to-acquire-idm-pharma-inc-for-75-million-adding-mepact-r-mifamurtide-the-first-treatment-approved-for-osteosarc
Takeda Pharmaceutical Co. Ltd. to Acquire IDM Pharma, Inc. for $75 Million, Adding MEPACT(R)...
takeda pharmaceutical co ltd
https://www.takeda.com/jp/newsroom/local-newsreleases/2024/takeda-announces-new-president-of-japan-pharma-business-unit-en/
Takeda Announces New President of Japan Pharma Business Unit
Takeda Announces New President of Japan Pharma Business Unit
president of japanpharma businesstakedaannouncesnew